Blood technologies company Entegrion has been awarded a $43.7 million defense contract to develop one of its investigational blood products into a substitute for fresh frozen plasma. The Department of Defense will fund development of Resusix, Entegrion’s dehydrated human plasma. Resusix will become Entegrion’s first investigational new drug application filing. Research Triangle Park, North Carolina-based […]
North Carolina biotechnology company Entegrion is in line to receive up to $9.84 million from the U.S. Navy, which wants to develop two of the company’s investigational blood products into a single life-saving fluid for use in combat situations. The Navy extended an existing contract with Research Triangle Park, North Carolina-based Entegrion in order to […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Updated 4:06 p.m. North Carolina life sciences company Entegrion has licensed its blood-clotting bandage to newly formed Chicago company Beeken BioMedical. Research Triangle Park-based Entegrion developed the bandage, called Stasilon, which is made of a proprietary weave of glass and bamboo fibers, two materials that promote clotting. Entegrion has received U.S. Food and Drug Administration […]
For its 9th birthday, the North Carolina biotech Entegrion is giving itself a present: a product on the market. The Research Triangle Park company has struck a licensing deal with a Boston-based medical device company to manufacture and market Entegrion’s Stasilon bandage: a proprietary weave of glass and bamboo fibers that promotes clotting. Chief Technology […]